{"id":"tropisetron","rwe":[],"tags":[{"label":"tropisetron","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"5-hydroxytryptamine receptor 3A","category":"target"},{"label":"HTR3A","category":"gene"},{"label":"HTR3B","category":"gene"},{"label":"HTR1A","category":"gene"},{"label":"A04AA03","category":"atc"},{"label":"Active","category":"status"},{"label":"Chemotherapy-induced nausea and vomiting","category":"indication"},{"label":"Antiemetics","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Gastrointestinal Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Serotonin 5-HT3 Receptor Antagonists","category":"pharmacology"},{"label":"Serotonin Agents","category":"pharmacology"},{"label":"Serotonin Antagonists","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":196.226,"date":"","count":60,"signal":"Myelosuppression","source":"DrugCentral FAERS","actionTaken":"Reported 60 times (LLR=196)"},{"llr":158.354,"date":"","count":55,"signal":"Bone marrow failure","source":"DrugCentral FAERS","actionTaken":"Reported 55 times (LLR=158)"},{"llr":118.338,"date":"","count":66,"signal":"White blood cell count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 66 times (LLR=118)"},{"llr":108.599,"date":"","count":63,"signal":"Platelet count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 63 times (LLR=109)"},{"llr":96.458,"date":"","count":45,"signal":"Neutrophil count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 45 times (LLR=96)"},{"llr":66.893,"date":"","count":30,"signal":"Hepatotoxicity","source":"DrugCentral FAERS","actionTaken":"Reported 30 times (LLR=67)"},{"llr":54.455,"date":"","count":28,"signal":"Hepatic function abnormal","source":"DrugCentral FAERS","actionTaken":"Reported 28 times (LLR=54)"},{"llr":47.359,"date":"","count":12,"signal":"Hypoproteinaemia","source":"DrugCentral FAERS","actionTaken":"Reported 12 times (LLR=47)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=TROPISETRON","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:08:42.609228+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Tropisetron","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T01:08:50.461101+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:08:49.173477+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TROPISETRON","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:08:49.889503+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4303202/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:08:50.345223+00:00"}},"allNames":"navoban","offLabel":[],"synonyms":["tropisetron","navoban","tropisetron hydrochloride","tropisetron HCl"],"timeline":[{"date":"1992-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1992-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Navoban","ecosystem":[{"indication":"Chemotherapy-induced nausea and vomiting","otherDrugs":[{"name":"aprepitant","slug":"aprepitant","company":"Merck"},{"name":"dronabinol","slug":"dronabinol","company":"Abbvie"},{"name":"estrone","slug":"estrone","company":"Watson Labs"},{"name":"fosaprepitant","slug":"fosaprepitant","company":""}],"globalPrevalence":null}],"mechanism":{"target":"5-hydroxytryptamine receptor 3A","targets":[{"gene":"HTR3A","source":"DrugCentral","target":"5-hydroxytryptamine receptor 3A","protein":"5-hydroxytryptamine receptor 3A"},{"gene":"HTR3B","source":"DrugCentral","target":"5-hydroxytryptamine receptor 3B","protein":"5-hydroxytryptamine receptor 3B"},{"gene":"HTR1A","source":"DrugCentral","target":"5-hydroxytryptamine receptor 1A","protein":"5-hydroxytryptamine receptor 1A"},{"gene":"CHRNA7","source":"DrugCentral","target":"Neuronal acetylcholine receptor subunit alpha-7","protein":"Neuronal acetylcholine receptor subunit alpha-7"},{"gene":"HTR4","source":"DrugCentral","target":"5-hydroxytryptamine receptor 4","protein":"5-hydroxytryptamine receptor 4"},{"gene":"SLC6A4","source":"DrugCentral","target":"Sodium-dependent serotonin transporter","protein":"Sodium-dependent serotonin transporter"},{"gene":"CHRM5","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M5","protein":"Muscarinic acetylcholine receptor M5"},{"gene":"GLRB","source":"DrugCentral","target":"Glycine receptor subunit beta","protein":"Glycine receptor subunit beta"},{"gene":"GLRA2","source":"DrugCentral","target":"Glycine receptor subunit alpha-2","protein":"Glycine receptor subunit alpha-2"},{"gene":"CHRNA3","source":"DrugCentral","target":"Neuronal acetylcholine receptor subunit alpha-3","protein":"Neuronal acetylcholine receptor subunit alpha-3"}],"modality":"Small Molecule","drugClass":"tropisetron","explanation":"","oneSentence":"","technicalDetail":"Navoban acts as a selective 5-HT3 receptor antagonist, competitively inhibiting the binding of serotonin to the 5-HT3 receptor, which is involved in the vomiting reflex."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Tropisetron","title":"Tropisetron","extract":"Tropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy, although it has been used experimentally as an analgesic in cases of fibromyalgia."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2775","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=TROPISETRON","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TROPISETRON","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Tropisetron","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T16:10:10.393369","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:08:52.251819+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ondansetron","drugSlug":"ondansetron","fdaApproval":"1991-01-04","patentExpiry":"Nov 23, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"granisetron","drugSlug":"granisetron","fdaApproval":"1993-12-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"dolasetron","drugSlug":"dolasetron","fdaApproval":"1997-09-11","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"palonosetron","drugSlug":"palonosetron","fdaApproval":"2003-07-25","genericCount":16,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"tropisetron","indications":{"approved":[{"name":"Chemotherapy-induced nausea and vomiting","source":"DrugCentral","snomedId":236084000,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ondansetron","brandName":"ondansetron","genericName":"ondansetron","approvalYear":"1991","relationship":"same-class"},{"drugId":"granisetron","brandName":"granisetron","genericName":"granisetron","approvalYear":"1993","relationship":"same-class"},{"drugId":"dolasetron","brandName":"dolasetron","genericName":"dolasetron","approvalYear":"1997","relationship":"same-class"},{"drugId":"palonosetron","brandName":"palonosetron","genericName":"palonosetron","approvalYear":"2003","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07484867","phase":"","title":"Effect of CYP2D6 on Perioperative Analgesia of Oxycodone in Elderly Patients","status":"COMPLETED","sponsor":"Henan Provincial People's Hospital","startDate":"2025-01-01","conditions":["Pain","Pulmonary Nodules","Oxycodone"],"enrollment":100,"completionDate":"2025-09-30"},{"nctId":"NCT07478692","phase":"NA","title":"Effects of Transversus Abdominis Plane Block on Recovery Quality and Maternal-Neonatal Outcomes After Cesarean Delivery","status":"COMPLETED","sponsor":"Qing Yuan","startDate":"2025-06-01","conditions":["Postoperative Pain After Cesarean Section"],"enrollment":83,"completionDate":"2025-10-31"},{"nctId":"NCT07413809","phase":"PHASE3","title":"Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen","status":"RECRUITING","sponsor":"The Affiliated People's Hospital of Ningbo University","startDate":"2025-10-31","conditions":["Multiple Myeloma"],"enrollment":92,"completionDate":"2027-09"},{"nctId":"NCT06952920","phase":"PHASE3","title":"Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2025-08-21","conditions":["Standard Quadruple Antiemetic Therapy","Electroacupuncture","Chemotherapy-induced Gastrointestinal Symptom Cluster"],"enrollment":388,"completionDate":"2028-06-30"},{"nctId":"NCT04817189","phase":"PHASE4","title":"Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2021-02-01","conditions":["Chemotherapy-induced Nausea and Vomiting"],"enrollment":414,"completionDate":"2024-07-02"},{"nctId":"NCT06785350","phase":"NA","title":"Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-01-25","conditions":["Pain Management","Spine Surgery"],"enrollment":535,"completionDate":"2025-12-01"},{"nctId":"NCT06200168","phase":"PHASE3","title":"Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2024-01-16","conditions":["Electroacupuncture","Olanzapine-contained Four-drug Antiemetic","Nausea and Vomiting"],"enrollment":370,"completionDate":"2026-12-31"},{"nctId":"NCT06772545","phase":"NA","title":"Study on the Effects of Multimodal Analgesia Regimens on Postoperative Analgesia and Gastrointestinal Function Recovery After Laparoscopic Abdominal Surgery","status":"NOT_YET_RECRUITING","sponsor":"Xiaguang Duan","startDate":"2025-02-01","conditions":["Laparoscopic Abdominal Surgery"],"enrollment":120,"completionDate":"2025-05-10"},{"nctId":"NCT06684210","phase":"NA","title":"Study of the Clinical Effect of External Oblique Muscle Intercostal Muscle Plane Block in Abdominal Surgery","status":"COMPLETED","sponsor":"The First Hospital of Qinhuangdao","startDate":"2023-03-01","conditions":["Nerve Block","Pain"],"enrollment":60,"completionDate":"2024-02-01"},{"nctId":"NCT06668298","phase":"NA","title":"Clinical Study of G Protein Biased Μ - Opioid Receptor Agonist Oliceridine for Optimizing Postoperative Analgesia Under General Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"Henan Provincial People's Hospital","startDate":"2024-11","conditions":["Old Age"],"enrollment":150,"completionDate":"2025-06"},{"nctId":"NCT05242874","phase":"PHASE3","title":"Anti-emetic Prophylaxis With or Without Dexamethasone","status":"COMPLETED","sponsor":"Henan Cancer Hospital","startDate":"2022-02-01","conditions":["Chemotherapy-induced Nausea and Vomiting"],"enrollment":442,"completionDate":"2023-08-15"},{"nctId":"NCT05331651","phase":"PHASE4","title":"Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2022-04-21","conditions":["Postoperative Nausea and Vomiting"],"enrollment":480,"completionDate":"2023-06-30"},{"nctId":"NCT01843868","phase":"NA","title":"Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP","status":"WITHDRAWN","sponsor":"Australasian Leukaemia and Lymphoma Group","startDate":"2012-01","conditions":["Lymphoma, Non-Hodgkin"],"enrollment":0,"completionDate":"2015-06"},{"nctId":"NCT06437886","phase":"NA","title":"High-dose Opioid Versus Opioid-sparing Anaesthesia in Cardiac Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2024-04-22","conditions":["Cardiac Surgery Patients"],"enrollment":80,"completionDate":"2024-07-22"},{"nctId":"NCT05533281","phase":"PHASE4","title":"Efficacy of Three Antiemetics in Preventing Nausea and Vomiting","status":"COMPLETED","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2022-09-15","conditions":["Nausea and Vomiting"],"enrollment":200,"completionDate":"2023-11-03"},{"nctId":"NCT05564286","phase":"PHASE3","title":"Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer","status":"COMPLETED","sponsor":"Shantou University Medical College","startDate":"2021-07-01","conditions":["Cervical Cancer","Nasopharyngeal Cancer","Chemotherapy-induced Nausea and Vomiting","Radiation-Induced Nausea and Vomiting","Antiemetic"],"enrollment":116,"completionDate":"2023-08-30"},{"nctId":"NCT06118216","phase":"NA","title":"Costal Cartilage Donor-site Pain: Does Abdominal Muscle Infiltration Analgesia Work?","status":"COMPLETED","sponsor":"Xiaohui Su","startDate":"2022-12-01","conditions":["Rectus Abdominis and External Oblique Muscle Infiltration Analgesia"],"enrollment":60,"completionDate":"2023-07-01"},{"nctId":"NCT01298193","phase":"PHASE4","title":"Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.","status":"COMPLETED","sponsor":"Spanish Breast Cancer Research Group","startDate":"2011-05","conditions":["Breast Cancer"],"enrollment":212,"completionDate":"2014-04"},{"nctId":"NCT05515822","phase":"PHASE4","title":"Use of Oxycodone in Bariatric Surgery","status":"UNKNOWN","sponsor":"Qiang Fu","startDate":"2022-10-01","conditions":["Pain, Postoperative"],"enrollment":90,"completionDate":"2024-09-01"},{"nctId":"NCT04195204","phase":"PHASE4","title":"A Pilot Trial Evaluating the Effect of Tropisetron on Postoperative Cognitive Dysfunction After Cardiac Surgery","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2020-11-01","conditions":["Postoperative Cognitive Dysfunction","Postoperative Delirium"],"enrollment":72,"completionDate":"2023-06-30"},{"nctId":"NCT04454866","phase":"NA","title":"Penehyclidine for Prevention of Nausea and Vomiting After Bimaxillary Surgery","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2020-07-07","conditions":["Penehyclidine","Postoperative Nausea and Vomiting","Bimaxillar Surgery"],"enrollment":354,"completionDate":"2021-04-15"},{"nctId":"NCT02909478","phase":"PHASE3","title":"Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2017-09-01","conditions":["Chemotherapy-induced Nausea and Vomiting","Colorectal Cancer"],"enrollment":315,"completionDate":"2019-12-31"},{"nctId":"NCT03571126","phase":"PHASE4","title":"Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer","status":"UNKNOWN","sponsor":"Zunyi Medical College","startDate":"2019-05-09","conditions":["Chemotherapy-induced Nausea and Vomiting","Lung Cancer"],"enrollment":156,"completionDate":"2023-08-01"},{"nctId":"NCT03325816","phase":"PHASE1,PHASE2","title":"Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2017-11-20","conditions":["Small Cell Lung Cancer","Small Cell Lung Cancer Extensive Stage"],"enrollment":9,"completionDate":"2020-08-11"},{"nctId":"NCT02195921","phase":"NA","title":"Acupuncture for Chemotherapy-Induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2015-04","conditions":["Chemotherapy-induced Nausea and Vomiting"],"enrollment":160,"completionDate":"2017-01"},{"nctId":"NCT04613869","phase":"NA","title":"The Effect of Esketamine on Patients Undergoing Tumor Surgery","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-08-15","conditions":["Tumor Surgery"],"enrollment":282,"completionDate":"2021-10-15"},{"nctId":"NCT02195908","phase":"NA","title":"The Different Effectiveness of Single Acupoint（PC6 or CV12) vs Matching Acupoints(PC6 and CV12) in Chemotherapy-induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2014-08","conditions":["to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting"],"enrollment":160,"completionDate":"2015-10"},{"nctId":"NCT04027751","phase":"PHASE4","title":"The Efficacy and Safety of Tropisetron in Preventing Emergence Delirium","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2019-08-01","conditions":["Emergence Delirium","Postoperative Delirium"],"enrollment":1508,"completionDate":"2022-03-31"},{"nctId":"NCT02625181","phase":"NA","title":"Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2016-07","conditions":["Postoperative Nausea and Vomiting"],"enrollment":27034,"completionDate":"2017-11-30"},{"nctId":"NCT03540537","phase":"NA","title":"A Trial Comparing Quadratus Lumborum Block (QLB) and Paravertebral Block (PVTB) for Postoperative Analgesia in Hepatectomy","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2018-05-09","conditions":["Quadratus Lumborum Block","Thoracic Paravertebral Block","Postoperative Analgesia","Hepatectomy"],"enrollment":180,"completionDate":"2020-12-31"},{"nctId":"NCT01636947","phase":"PHASE4","title":"A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-12-12","conditions":["Nausea","Vomiting"],"enrollment":494,"completionDate":"2014-08-04"},{"nctId":"NCT01594749","phase":"PHASE3","title":"Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-09-24","conditions":["Chemotherapy-Induced Nausea and Vomiting (CINV)"],"enrollment":1015,"completionDate":"2014-11-03"},{"nctId":"NCT03061396","phase":"NA","title":"The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints","status":"UNKNOWN","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2017-02-17","conditions":["Electro-acupuncture","Chemotherapy-induced Nausea and Vomiting"],"enrollment":208,"completionDate":"2018-05-28"},{"nctId":"NCT02479581","phase":"PHASE2","title":"The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Xiangya Hospital of Central South University","startDate":"2015-07","conditions":["Valvular Heart Disease"],"enrollment":226,"completionDate":"2017-05"},{"nctId":"NCT00435370","phase":"PHASE3","title":"Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2006-11","conditions":["Smoking Cessation","Schizophrenia"],"enrollment":179,"completionDate":"2011-08"},{"nctId":"NCT02576327","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Jun Zhu","startDate":"2015-10","conditions":["Vomiting"],"enrollment":130,"completionDate":"2017-12"},{"nctId":"NCT00003817","phase":"PHASE2","title":"Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy","status":"COMPLETED","sponsor":"Gary Morrow","startDate":"1999-10","conditions":["Nausea and Vomiting","Unspecified Adult Solid Tumor, Protocol Specific"],"enrollment":700,"completionDate":"2001-07"},{"nctId":"NCT02096835","phase":"NA","title":"Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2014-01","conditions":["Postoperative Nausea and Vomiting"],"enrollment":157,"completionDate":"2015-01"},{"nctId":"NCT02478047","phase":"NA","title":"Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting","status":"UNKNOWN","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2015-06","conditions":["Chemotherapy-induced Nausea and Vomiting"],"enrollment":240,"completionDate":"2016-09"},{"nctId":"NCT01895010","phase":"PHASE2","title":"Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2013-06","conditions":["Nausea","Vomiting","Metastatic Liver Cancer"],"enrollment":74,"completionDate":"2014-12"},{"nctId":"NCT00970450","phase":"NA","title":"The Central Analgesic Effects of Paracetamol on Serotonergic Pathways","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2009-11","conditions":["Analgesia"],"enrollment":16,"completionDate":"2010-04"},{"nctId":"NCT01101529","phase":"PHASE2","title":"Treatment of Chemotherapy-induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Uppsala University Hospital","startDate":"2010-05","conditions":["Nausea","Vomiting"],"enrollment":90,"completionDate":"2012-12"},{"nctId":"NCT00889499","phase":"PHASE2","title":"Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2009-03","conditions":["Pain","Chronic Disease"],"enrollment":30,"completionDate":"2010-04"},{"nctId":"NCT01304953","phase":"PHASE4","title":"Tropisetron on Postoperative Pain","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2010-01","conditions":["Pain, Postoperative"],"enrollment":296,"completionDate":"2010-12"},{"nctId":"NCT00487110","phase":"PHASE4","title":"Clinical Confirmation of a Pharmacodynamic Interaction Between Tropisetron and Paracetamol","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2008-06","conditions":["Pain"],"enrollment":40,"completionDate":"2009-06"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004472","UNII":"6I819NIK1W","CHEBI":"CHEBI:32269","INN_ID":"6535","RXNORM":"235997","UMLSCUI":"C0063322","chemblId":"CHEMBL4303202","ChEMBL_ID":"CHEMBL56564","KEGG_DRUG":"D02041","DRUGBANK_ID":"DB11699","PDB_CHEM_ID":" TKT","PUBCHEM_CID":"656665","SNOMEDCT_US":"322201005","IUPHAR_LIGAND_ID":"260","SECONDARY_CAS_RN":"105826-92-4","MESH_DESCRIPTOR_UI":"D000077526"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"5.6 hours","clearance":"26.0 mL/min/kg","bioavailability":"66%","volumeOfDistribution":"9.7 L/kg"},"publicationCount":1029,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"A04AA03","allCodes":["A04AA03"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Navoban is a small molecule with a modality of a small molecule. It has been studied in clinical trials for conditions including analgesia, chemotherapy-induced nausea and vomiting, lung cancer, and postoperative nausea and vomiting.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1992-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:08:52.251819+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}